Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-05
DOI
10.1002/ajh.25603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer
- (2019) Giancarlo Agnelli NEW ENGLAND JOURNAL OF MEDICINE
- Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients
- (2019) Thierry Facon et al. BLOOD
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
- (2018) Emelia J. Benjamin et al. CIRCULATION
- A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
- (2018) Jesús F. San-Miguel et al. HAEMATOLOGICA
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data
- (2018) Eric M. Ammann et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic classification of death causes in multiple myeloma
- (2018) Elias K. Mai et al. Blood Cancer Journal
- A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
- (2018) Jesús F. San-Miguel et al. HAEMATOLOGICA
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).
- (2018) Kristen Marie Sanfilippo et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
- (2018) Martin W. Schoen et al. JOURNAL OF CLINICAL ONCOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
- (2017) Nick van Es et al. HAEMATOLOGICA
- External validation of the DASH prediction rule: a retrospective cohort study
- (2017) A. Tosetto et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
- (2017) Brian G M Durie et al. LANCET
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
- (2017) Nick van Es et al. HAEMATOLOGICA
- Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies
- (2017) Weijuan Li et al. JAMA Oncology
- Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
- (2016) Roongruedee Chaiteerakij et al. JOURNAL OF CLINICAL ONCOLOGY
- The epidemiology of venous thromboembolism
- (2016) John A. Heit et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Aspirin Use Among Adults in the U.S.
- (2015) Craig D. Williams et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
- (2015) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data
- (2015) Kristen M. Sanfilippo et al. THROMBOSIS RESEARCH
- Aspirin for the Prevention of Recurrent Venous Thromboembolism
- (2014) John Simes et al. CIRCULATION
- Venous Thromboembolism in Patients With Myeloma
- (2014) Maeve P. Crowley et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma
- (2014) Joanna Rupa-Matysek et al. THROMBOSIS RESEARCH
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population
- (2013) Yingjun Zhou et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
- (2012) M. Cavo et al. BLOOD
- Thrombosis is associated with inferior survival in multiple myeloma
- (2012) S. Y. Kristinsson et al. HAEMATOLOGICA
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma
- (2008) M. Zangari et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now